The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
from NYT > U.S. News https://ift.tt/KI3RiNP
Post Top Ad
Friday, September 30, 2022
FDA Approves ALS Treatment Despite Questions About Effectiveness
Tags
# NYT > U.S. News
About Unknown
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates.
NYT > U.S. News
Labels:
NYT > U.S. News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment